Study identifies natural molecule that reduces pain sensitivity

Rutgers researchers have found a new way to manage the receptors that control the sense of touch, which could lead to treating chronic pain more effectively.

Cybersecurity Incident at Synnovis in UK – Biotech Investments

EQS-News: SYNLAB AG / Key word(s): Statement Cybersecurity Incident at Synnovis in UK 04.06.2024 / 20:46 CET/CEST The issuer is solely responsible for the content

June 6, 2024

UK’s life sciences sector sees $1.1B drop in foreign investments from 2021 to 2022

The UK’s pharma industry group is warning of a dire situation for the country’s life sciences sector, which saw a $1.1 billion (£0.9 billion) reduction

July 15, 2023

Pfizer and BioNTech’s Covid-19/flu combination vaccine falters in Phase III readout – Pharmaceutical Technology

Pfizer and BioNTech have announced that a Phase III trial studying their investigational combination mRNA vaccine for the treatment of influenza and Covid-19 has failed

August 16, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.